This paper compared the gene expression profiles of circulating tumor cells (CTCs) isolated by CellSearch with those from case-matched formalin-fixed paraffin-embedded (FFPE) primary tumor and metastatic tissue specimens.
Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
Onstenk W, Sieuwerts AM, Mostert B, Lalmahomed Z, Bolt-de Vries JB, van Galen A, Smid M, Kraan J, Van M, de Weerd V, Ramírez-Moreno R, Biermann K, Verhoef C, Grünhagen DJ, IJzermans JN, Gratama JW, Martens JW, Foekens JA, Sleijfer S
Purpose
Conclusion
The CTC gene expression profile was concordant with the liver metastasis in more patients (74%) than the corresponding primary tumor specimen (57%). Levels of concordance were not affected by time of metastasis presentation (synchronous or metachronous), number of metastases, chemotherapy, or patient age or gender. Nine of the 25 genes examined were downregulated in CTCs compared to primary tumor and seven were also downregulated when compared to liver metastases.
Studies (1)
Purpose
This study compared the gene expression profiles of CTCs isolated by CellSearch with those from case-matched FFPE primary tumor and metastatic tissue specimens. Peripheral blood (30 mL) was collected in CellSave and EDTA tubes from 23 patients with metastatic colorectal cancer just prior to liver surgery and processed within 24 h. Red blood cells were removed by a modified Ficoll density gradient and CTCs were isolated and enumerated using the CellSearch method. RNA was isolated from CTCs using the Qiagen AllPrep DNA/RNA Micro Kit. RNA was isolated using the High- Pure RNA Paraffin Kit from FFPE primary tumor and liver metastasis tissues with ≥30% tumor cells. Twenty-five CTC-specific genes were measured by real-time RT-qPCR and expression levels were normalized to three reference genes (GUSB, HMBS, and HPRT1).
Summary of Findings
Primary tumor and metastasis gene expression profiles were concordant in 16/23 patients (70%). CTC gene expression profiles were concordant with the liver metastasis in 17/23 patients (74%) and with the primary tumor in 13/23 patients (57%). Gene expression profiles of CTCs more closely resembled those from the liver metastasis in 13 patients and the primary tumor in five patients, but reflected characteristics from both the primary tumor and the liver metastasis in three patients, and did not resemble either the primary tumor nor the liver metastasis in two patients. Levels of concordance were not affected by time of metastasis presentation (synchronous or metachronous), number of metastases, chemotherapy, or patient age or gender. Only FCGBP was significantly downregulated in the liver metastases compared to the primary tumor (P=0.004) and CDH1, CDH17, CDX1, CEACAM5, FABP1, FCGBP, IGFBP3, IGFBP4, and MAPT were significantly downregulated in CTCs (P=0.001-0.03). Similarly, CDH1, CDH17, CDX1, CEACAM5, FABP1, IGFBP3, and MAPT were significantly downregulated in CTCs compared to liver metastases (P=0.001-0.02).
Biospecimens
FluidBloodTissueColorectalTissueLiverPreservation Types
Other PreservativeFormalinDiagnoses
NeoplasticCarcinomaPlatforms
Cell count/volumeFluorescent microscopyRNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition ChemotherapyMetachronous metastasis presentationNo chemotherapyNumber of metastasesSynchronous metastasis presentationPreaquisition Patient age 68 ± 10 yearsPreaquisition Patient gender FemaleMaleBiospecimen Acquisition Biospecimen location Circulating tumor cellLiver metastasisPrimary colorectal tumorReal-time qRT-PCR Specific Targeted nucleic acid AGR2AKR1C3CDH1CDH17CDH5CDX1CEACAM5COL4A1CXCL1FABP1FCGBPGPX2GUSBHMBSHPRT1IGFBP3IGFBP4IGFBP5KRT19KRT20LAD1MACROD1MAPTPRSS8RARRES2S100PTRIM2TSPAN8